A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects

Clinical trial NCT05735249 · COMPLETED

Trial details

NCT number: NCT05735249
Sponsor: Arisan Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Participants

Start date: 2023-01-23
Primary completion: 2025-03-28
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.